Coronary artery disease affects both men and women. In this study, we examine sex-specific differences in occurrence of major adverse cardiovascular events (MACEs) after coronary angiography.
Methods:
We analyzed data from the coronary angiography cohort Utrecht Coronary Biobank (n = 1283 men, 480 women). Using Kaplan-Meier and multivariable Cox-regression, we tested for sex differences in MACE occurrence. Additionally, we compared mortality with an age- and sex-matched control group from the general Dutch population.
Results:
During a median follow-up of 2.1 years (interquartile range 1.6-2.8), MACEs occurred in 265 men and 103 women (20.7% vs 21.3%, P = .744). Women with myocardial infarction (MI) had significantly more MACE during follow-up than men (hazard ratio [HR] 1.66 for female sex, 95% confidence interval [CI] 1.10-2.50, P = .015), which was also the case for women who had multivessel disease (HR 1.41, 95% CI 1.03-1.94, P = .031). During follow-up, mortality in women presenting with MI was higher than mortality of women in the general population; men with MI did not show this disadvantage.
Conclusion:
MACEs occurred more often in women than in men who presented with MI or who had angiographic multivessel disease upon coronary angiography. Clinical trial registration:Clinicaltrials.gov identifier: NCT02304744. URL: https://clinicaltrials.gov/ct2/show/NCT02304744.
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
2.
AppelmanYvan RijnBBTen HaafMEBoersmaEPeters S aE. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–218.
3.
ShawLJBairey MerzCNPepineCJ. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 suppl):S4–S20.
4.
JacobsAK. Coronary intervention in 2009: are women no different than men?Circ Cardiovasc Interv. 2009;2(1):69–78.
5.
MozaffarianDBenjaminEJGoAS. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2014;131(4):e29–e323.
6.
MoscaL. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association National Survey. Circulation. 2013;127(11):1–21.
7.
CasanovaGBossardi RamosRZiegelmannPSpritzerPM. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J Clin Endocrinol Metab. 2015;100(3):1028–1037.
8.
Bairey MerzCNShawLJReisSE. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular cor. J Am Coll Cardiol. 2006;47(3 suppl):S21–S29.
9.
Den RuijterHPasterkampGRuttenFH. Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program. Neth Heart J. 2015;23(2):89–93.
10.
GierachGLJohnsonBDBairey MerzCN. Hypertension, menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol. 2006;47(3 suppl):S50–S58.
11.
MoscaLBarrett-ConnorEWengerNK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011;124(19):2145–2154.
12.
NicholsMTownsendNScarboroughPRaynerM. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013;34(39):3017–3027.
13.
GijsbertsCMGoharAEllenbroekGHJM. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography. Atherosclerosis. 2015;241:234–240.
14.
ReitsmaJBKardaunJWPFGeversEDe BruinAVan Der WalJBonselGJ. Mogelijkheden voor anoniem follow-uponderzoek van patiënten in landelijke medische registraties met behulp van de Gemeentelijke Basisadministratie: Een pilotonderzoek. Ned Tijdschr Geneeskd. 2003;147(46):2286–2290.
15.
HarrisPJBeharVSConleyMJ. The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease. Circulation. 1980;62(2):240–248.
16.
SianosGMorelMKappeteinAP. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
17.
Syntaxscore.com [Internet]. Rotterdam: SYNTAX Score Calculator version 2.11; 2013. Web site. http://www.syntaxscore.com. Updated 2013. Accessed September 1, 2015.
18.
R-project.org [Internet]. Vienna: R: A Language and Environment for Statistical Computing; 2014. Web site. http://www.r-project.org. Updated August 14, 2015. Accessed September 1, 2015.
19.
StegPGGreenlawNTardifJC. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012;33(22):2831–2840.
20.
TomeyMIMehranRBrenerSJ. Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). Am Heart J. 2015;169(1):86–93.
21.
Van der MeerMGNathoeHMvan der GraafYDoevendansPAAppelmanY. Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest. 2015;45(2):226–235.
22.
SullivanALBeshanskyJRRuthazerRMurmanDHMaderTJSelkerHP. Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study. Circ Cardiovasc Qual Outcomes. 2014;7(1):86–94.
23.
FerranteGCorradaEBelliG. Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention. Can J Cardiol. 2011;27(6):749–755.
24.
WangTJLarsonMGLevyD. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90(3):254–258.
25.
RedfieldMMRodehefferRJJacobsenSJMahoneyDWBaileyKRBurnettJC. Plasma brain natriuretic peptide concentration: impact of age and gender. ACC Curr J Rev. 2003;12(1):44.
26.
Fernandez-JimenezRSilvaJMartinez-MartinezS. Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study. J Am Heart Assoc. 2015;4(1):e001218–e001218.
27.
HemingwayHLangenbergCDamantJFrostCPyöräläKBarrett-ConnorE. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117(12):1526–1536.
28.
ShawLJ. Women and ischemic heart disease: evolving knowledge. JACC. 2009;54(17):1561–1575.
29.
RuijterHM denHaitjemaSW AsselbergsFPasterkampG. Sex matters to the heart: a special issue dedicated to the impact of sex related differences of cardiovascular diseases. Atherosclerosis. 2015;241(1):205–207.
30.
ColvinMSweitzerNKAlbertNM. Heart failure in non-caucasians, women, and older adults: a white paper on special populations from the heart failure society of america guideline committee. J Card Fail. 2015;21(8):674–693.
31.
DahabrehIJ. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305(8):822.
32.
LanskyAJHochmanJSWardPA. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005;111(7):940–953.
33.
MurthyVLNayaMTaquetiVR. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518–2527.
34.
VoglerNMeyerMFinkCSchoepfUSchönbergSHenzlerT. Predictive value of zero calcium score and low-end percentiles for the presence of significant coronary artery stenosis in stable patients with suspected coronary artery disease. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgeb Verfahren. 2013;185(8):726–732.
35.
BlomkalnsALChenAYHochmanJS. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementatio. J Am Coll Cardiol. 2005;45(6):832–837.
36.
BrownMTBussellJK. Medication adherence: WHO cares?Mayo Clin Proc. 2011;86(4):304–314.
37.
RadovanovicDErnePUrbanPBertelORickliHGaspozJM. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart. 2007;93(11):1369–1375.
38.
VaughanCJGottoAM. Update on statins: 2003. Circulation. 2004;110(7):886–892.
39.
LeweyJShrankWHBowryADKKilabukEBrennanTAChoudhryNK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665–678.e1.
40.
AmsterdamEAWengerNKBrindisRG. 2014 AHA/ACC Guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;130(25):344–426.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
